Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Pancreatic Ductal”

632 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 632 results

Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT03697239
What this trial is testing

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Hitendra Patel
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207944
What this trial is testing

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Who this might be right for
IPMNIPMN, Pancreatic
Duke University 100
Not applicableUnknownNCT04855331
What this trial is testing

Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

Who this might be right for
Borderline Resectable Pancreatic Cancer
Fudan University 120
Testing effectiveness (Phase 2)Looking for participantsNCT06937177
What this trial is testing

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Who this might be right for
Cancer Weight Loss
Endevica Bio 120
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Not applicableUnknownNCT01942629
What this trial is testing

Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas

Who this might be right for
Lung AdenocarcinomaBreast AdenocarcinomaPancreatic Ductal Adenocarcinoma
Rambam Health Care Campus 300
Not applicableStudy completedNCT02790944
What this trial is testing

Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Ambry Genetics 300
Large-scale testing (Phase 3)Active Not RecruitingNCT04927780
What this trial is testing

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaResectable Pancreatic Adenocarcinoma
Erasmus Medical Center 378
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Not applicableNot Yet RecruitingNCT07621029
What this trial is testing

Venous Resection in Patients Undergoing Pancreatic Surgery

Who this might be right for
IPMN, PancreaticPancreatic Cancer, ResectedPancreatic Cancer Borderline+1 more
Sahlgrenska University Hospital 1,000
Not applicableLooking for participantsNCT07117045
What this trial is testing

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

Who this might be right for
Pancreatic CancerIntraductal Papillary Mucinous NeoplasmHigh-grade Pancreatic Intraepithelial Neoplasia+2 more
Changhai Hospital 400,000
Post-approval studies (Phase 4)Looking for participantsNCT07262957
What this trial is testing

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Who this might be right for
Pancreas Head CancerPancreas AdenocarcinomaIPMN, Pancreatic+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 400
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Testing effectiveness (Phase 2)Looking for participantsNCT07101679
What this trial is testing

GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma
West China Hospital 23
Testing effectiveness (Phase 2)Looking for participantsNCT06813079
What this trial is testing

Using Tumor Models to Determine Treatments

Who this might be right for
Pancreatic Ductal CarcinomaAdvanced CancerEpithelial Tumor
University Health Network, Toronto 25
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)WithdrawnNCT03374852
What this trial is testing

CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Next Page